{"nct_id":"NCT00154375","title":"Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma","status":"COMPLETED","status_verified_date":"2011-04","start_date":"2004-10","start_date_type":null,"primary_completion_date":"2008-08","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE3"],"tickers":["NVS"]}